Abbott’s Aveir DR leadless pacemaker, the first pacing offering of its kind to gain FDA approval, is linked to a consistent electrical performance six months after implant. Researchers tracked data from nearly 400 patients and presented their full findings in Heart Rhythm.

R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO. 

A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024 in Boston. 

The new recall impacts more than 85,000 devices. If users update their iPhone app as recommended, however, they can continue using the insulin pump as directed. 

Healthy diets that prioritize plant-based foods were associated with reductions in both all-cause mortality or CVD mortality. Diets do not have to be strictly vegan or vegetarian to make that impact, researchers noted. 

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

The update includes multiple new algorithms designed to improve efficiency during cardiac ablation procedures.

Interventional cardiologist Foluso Fakorede, MD, says everything from limited specialists to a lack of sidewalks are causing a disproportionate rate of minorities to be caught in the current PAD and CLI epidemic.